Search hospitals > New Mexico > Albuquerque
University of New Mexico
Claim this profileAlbuquerque, New Mexico 87102
Global Leader in Newborns
Global Leader in Cancer
Conducts research for Low Birth Weight
Conducts research for Premature Infants
Conducts research for Small for Gestational Age
373 reported clinical trials
43 medical researchers
Summary
University of New Mexico is a medical facility located in Albuquerque, New Mexico. This center is recognized for care of Newborns, Cancer, Low Birth Weight, Premature Infants, Small for Gestational Age and other specialties. University of New Mexico is involved with conducting 373 clinical trials across 634 conditions. There are 43 research doctors associated with this hospital, such as Carolyn Y. Muller, Ursa A. Brown-Glaberman, Kristi L Watterberg, MD, and Davin Quinn, MD.Top PIs
Carolyn Y. MullerUniversity of New Mexico Cancer Center1 year of reported clinical research
Studies Endometrial Cancer
Studies Parotid Gland Cancer
23 reported clinical trials
44 drugs studied
Ursa A. Brown-GlabermanUniversity of New Mexico Cancer Center5 years of reported clinical research
Studies Breast Cancer
Studies Parotid Gland Cancer
20 reported clinical trials
45 drugs studied
Kristi L Watterberg, MDUniversity of New Mexico6 years of reported clinical research
Studies Premature Infants
Studies Low Birth Weight
8 reported clinical trials
12 drugs studied
Davin Quinn, MDUniversity of New Mexico1 year of reported clinical research
Studies Traumatic Brain Injury
Studies Brain Injury
7 reported clinical trials
10 drugs studied
Clinical Trials running at University of New Mexico
Multiple Sclerosis
Stroke
Urinary Incontinence
Traumatic Brain Injury
Overactive Bladder
Primary Lateral Sclerosis
Diabetes Mellitus
Type 2 Diabetes
Post-Implantation Syndrome
Age-Related Macular Degeneration
Frexalimab
for Multiple Sclerosis
The study is evaluating whether Frexalimab performs better than the existing MS medication, Teriflunomide, at reducing the number of relapses in patients with relapsing forms of multiple sclerosis.
Recruiting1 award Phase 319 criteria
Frexalimab
for Multiple Sclerosis
The study is evaluating the efficacy and safety of Frexalimab in patients with non-relapsing, secondary progressive MS. The primary objective is to determine whether Frexalimab can delay disability progression compared to placebo.
Recruiting1 award Phase 312 criteria
Tolebrutinib
for Multiple Sclerosis
This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥18 years) with RMS, PPMS, or NRSPMS who were previously enrolled in the Phase 2b LTS (LTS16004) or 1 of the 4 Phase 3 tolebrutinib pivotal trials (GEMINI 1 \[EFC16033\], GEMINI 2 \[EFC16034\], HERCULES \[EFC16645\], or PERSEUS \[EFC16035\]). SUBSTUDY: ToleDYNAMIC substudy
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at University of New Mexico?
Where is University of New Mexico located?
Who should I call to ask about financial aid or insurance network?
What insurance does University of New Mexico accept?
What awards or recognition has University of New Mexico received?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.